ALVMG.PA
Price:
$0.1726
Market Cap:
$52.99M
Visiomed Group SA develops and distributes electronic medical devices in Europe and internationally. It provides thermometers, blood pressure monitors, pulse oximeters, connected blood glucometers, and connected electrocardiograms; and pain relief products, such as electrotherapy. The company also offers connected scales and scalable baby scales, as well as prevention and treatment products, such as humidifiers and phototherapies. In addition, it provides hearing products and optics, including presbycusis, as well as family hygiene products. The company offers its products under the ThermoFlash, T. LeClerc, Visiocheck, Innoxa, and BewellConnect brands. Visiomed Group SA was founded in 2007 a...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
2011-07-11
Stock Exchange
EURONEXT
Ticker
ALVMG.PA
According to Visiomed Group SA’s latest financial reports and current stock price. The company's current ROE is 3.84%. This represents a change of -190.39% compared to the average of -4.25% of the last 4 quarters.
The mean historical ROE of Visiomed Group SA over the last ten years is -532.91%. The current 3.84% ROE has changed -100.72% with respect to the historical average. Over the past ten years (40 quarters), ALVMG.PA's ROE was at its highest in in the December 2019 quarter at 222.10%. The ROE was at its lowest in in the June 2019 quarter at -394.41%.
Average
-532.91%
Median
-45.35%
Minimum
-5478.86%
Maximum
470.89%
Discovering the peaks and valleys of Visiomed Group SA ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 5.17%
Maximum Annual ROE = 470.89%
Minimum Annual Increase = -127.12%
Minimum Annual ROE = -5478.86%
Year | ROE | Change |
---|---|---|
2023 | 3.74% | -117.21% |
2022 | -21.74% | -31.34% |
2021 | -31.67% | -127.12% |
2020 | 116.75% | -75.21% |
2019 | 470.89% | -108.59% |
2018 | -5478.86% | 5.17% |
2017 | -103.89% | -36.87% |
2016 | -164.57% | 170.95% |
2015 | -60.74% | 2.88% |
2014 | -59.04% | 19.34% |
The current ROE of Visiomed Group SA (ALVMG.PA) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-16.55%
5-year avg
107.60%
10-year avg
-532.91%
Visiomed Group SA’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Visiomed Group SA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Visiomed Group SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Visiomed Group SA's ROE?
How is the ROE calculated for Visiomed Group SA (ALVMG.PA)?
What is the highest ROE for Visiomed Group SA (ALVMG.PA)?
What is the 3-year average ROE for Visiomed Group SA (ALVMG.PA)?
What is the 5-year average ROE for Visiomed Group SA (ALVMG.PA)?
How does the current ROE for Visiomed Group SA (ALVMG.PA) compare to its historical average?